Digitek Plaintiffs Want 2nd Look At Class Cert.
Plaintiffs who lost a bid for class certification in multidistrict litigation over the recall of Actavis Inc. and Mylan Inc.'s heart drug Digitek have asked the judge to reconsider his decision,...To view the full article, register now.
Already a subscriber? Click here to view full article